← Back to Clinical Trials
Recruiting NCT07620873

NCT07620873 Effects of Virtual Reality Education on Anxiety and Learning in Patients Undergoing Urolithiasis Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07620873
Status Recruiting
Phase
Sponsor Wei-Lin, Huang
Condition Urolithiasis
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2026-06-28
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
VR EducationTwo-Tier VR Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2026-06-28 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to evaluate the effects of two-tier virtual reality-based preoperative education on anxiety, learning knowledge, self-care ability, and cognitive load in patients undergoing urolithiasis surgery. Participants will be randomly assigned to routine education, standard virtual reality education, or two-tier virtual reality education groups. Outcomes will be assessed using anxiety scales, knowledge questionnaires, self-care ability measures, and cognitive load assessments before and after the intervention.

Eligibility Criteria

Inclusion Criteria: * Patients scheduled to undergo urolithiasis surgery with procedure codes 77026B, 77027B, 77028B, or 76016B. * Aged 18 years or older. * Conscious and mentally alert. * Able to communicate in Mandarin Chinese and read written text. * Able to understand and operate virtual reality equipment. Exclusion Criteria: * Patients with current psychiatric disorders or substance abuse. * Patients with hearing or visual impairment. * Patients with visual dizziness, vertigo, or virtual reality motion sickness symptoms. * Patients who are unable to cooperate or unwilling to participate in the study.

Contact & Investigator

Central Contact

wellin Huang, RN, MSN Student

✉ hwl0111@gmail.com

📞 +886 953713535

Frequently Asked Questions

Who can join the NCT07620873 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Urolithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07620873 currently recruiting?

Yes, NCT07620873 is actively recruiting participants. Contact the research team at hwl0111@gmail.com for enrollment information.

Where is the NCT07620873 trial being conducted?

This trial is being conducted at Keelung, Taiwan.

Who is sponsoring the NCT07620873 clinical trial?

NCT07620873 is sponsored by Wei-Lin, Huang. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology